Carl Zeiss Meditec AG (CZMWF)
USD 65.07
(12.44%)
USD 65.07
(12.44%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 290.39 Million EUR | -1.2% |
| 2022 | 293.9 Million EUR | 24.39% |
| 2021 | 236.27 Million EUR | 93.06% |
| 2020 | 122.38 Million EUR | -23.39% |
| 2019 | 159.75 Million EUR | 26.33% |
| 2018 | 126.46 Million EUR | -5.94% |
| 2017 | 134.44 Million EUR | 36.73% |
| 2016 | 98.33 Million EUR | 57.84% |
| 2015 | 62.29 Million EUR | -16.89% |
| 2014 | 74.95 Million EUR | -18.64% |
| 2013 | 92.13 Million EUR | 28.19% |
| 2012 | 71.87 Million EUR | 7.42% |
| 2011 | 66.9 Million EUR | 21.98% |
| 2010 | 54.84 Million EUR | 8.52% |
| 2009 | 50.54 Million EUR | -6.48% |
| 2008 | 54.04 Million EUR | 13.17% |
| 2007 | 47.75 Million EUR | 78.95% |
| 2006 | 26.68 Million EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 46.47 Million EUR | 24.27% |
| 2024 Q1 | 37.4 Million EUR | -56.1% |
| 2024 Q3 | 34.13 Million EUR | -26.57% |
| 2023 Q4 | 85.19 Million EUR | -7.55% |
| 2023 Q2 | 62 Million EUR | 21.57% |
| 2023 Q1 | 51 Million EUR | -50.35% |
| 2023 Q3 | 92.15 Million EUR | 48.62% |
| 2023 FY | 290.39 Million EUR | -1.2% |
| 2022 FY | 293.9 Million EUR | 24.39% |
| 2022 Q1 | 37.9 Million EUR | -29.91% |
| 2022 Q2 | 90.72 Million EUR | 139.39% |
| 2022 Q3 | 62.53 Million EUR | -31.08% |
| 2022 Q4 | 102.7 Million EUR | 64.25% |
| 2021 Q1 | 46.3 Million EUR | -12.95% |
| 2021 Q4 | 54.07 Million EUR | -33.72% |
| 2021 Q3 | 81.58 Million EUR | 50.23% |
| 2021 Q2 | 54.3 Million EUR | 17.3% |
| 2021 FY | 236.27 Million EUR | 93.06% |
| 2020 Q2 | 25.09 Million EUR | -35.33% |
| 2020 FY | 122.38 Million EUR | -23.39% |
| 2020 Q4 | 53.18 Million EUR | 905.39% |
| 2020 Q3 | 5.29 Million EUR | -78.92% |
| 2020 Q1 | 38.8 Million EUR | -23.71% |
| 2019 Q1 | 28.7 Million EUR | -35.6% |
| 2019 Q2 | 29.39 Million EUR | 2.4% |
| 2019 Q3 | 50.82 Million EUR | 72.92% |
| 2019 Q4 | 50.85 Million EUR | 0.07% |
| 2019 FY | 159.75 Million EUR | 26.33% |
| 2018 FY | 126.46 Million EUR | -5.94% |
| 2018 Q1 | 28.5 Million EUR | -32.05% |
| 2018 Q2 | 27.57 Million EUR | -3.26% |
| 2018 Q3 | 25.86 Million EUR | -6.18% |
| 2018 Q4 | 44.56 Million EUR | 72.26% |
| 2017 Q4 | 41.94 Million EUR | 36.35% |
| 2017 Q3 | 30.76 Million EUR | -0.4% |
| 2017 Q2 | 30.88 Million EUR | -0.05% |
| 2017 Q1 | 30.9 Million EUR | 1.14% |
| 2017 FY | 134.44 Million EUR | 36.73% |
| 2016 Q1 | 16.7 Million EUR | 67.05% |
| 2016 Q3 | 19.78 Million EUR | -36.75% |
| 2016 Q4 | 30.55 Million EUR | 54.45% |
| 2016 FY | 98.33 Million EUR | 57.84% |
| 2016 Q2 | 31.27 Million EUR | 87.27% |
| 2015 FY | 62.29 Million EUR | -16.89% |
| 2015 Q4 | 9.99 Million EUR | -55.05% |
| 2015 Q2 | 11.73 Million EUR | -35.97% |
| 2015 Q1 | 18.32 Million EUR | 4.77% |
| 2015 Q3 | 22.23 Million EUR | 89.5% |
| 2014 Q2 | 19.37 Million EUR | -3.6% |
| 2014 FY | 74.95 Million EUR | -18.64% |
| 2014 Q4 | 17.49 Million EUR | -2.76% |
| 2014 Q3 | 17.98 Million EUR | -7.15% |
| 2014 Q1 | 20.09 Million EUR | -26.58% |
| 2013 Q1 | 23.32 Million EUR | 55.24% |
| 2013 FY | 92.13 Million EUR | 28.19% |
| 2013 Q2 | 19.12 Million EUR | -18.03% |
| 2013 Q3 | 23.99 Million EUR | 25.52% |
| 2013 Q4 | 27.37 Million EUR | 14.07% |
| 2012 Q4 | 15.02 Million EUR | 11.25% |
| 2012 Q1 | 16.9 Million EUR | -6.32% |
| 2012 FY | 71.87 Million EUR | 7.42% |
| 2012 Q3 | 13.5 Million EUR | -39.66% |
| 2012 Q2 | 22.38 Million EUR | 32.42% |
| 2011 Q3 | 16.11 Million EUR | -15.1% |
| 2011 Q1 | 13.76 Million EUR | -37.32% |
| 2011 Q2 | 18.98 Million EUR | 37.93% |
| 2011 Q4 | 18.04 Million EUR | 11.98% |
| 2011 FY | 66.9 Million EUR | 21.98% |
| 2010 FY | 54.84 Million EUR | 8.52% |
| 2010 Q2 | 10.86 Million EUR | -3.85% |
| 2010 Q3 | 10.76 Million EUR | -0.87% |
| 2010 Q4 | 21.95 Million EUR | 103.89% |
| 2010 Q1 | 11.29 Million EUR | -37.54% |
| 2009 Q2 | 10.9 Million EUR | -14.37% |
| 2009 Q3 | 8.8 Million EUR | -19.26% |
| 2009 FY | 50.54 Million EUR | -6.48% |
| 2009 Q4 | 18.09 Million EUR | 105.4% |
| 2009 Q1 | 12.73 Million EUR | 0.0% |
| 2008 FY | 54.04 Million EUR | 13.17% |
| 2007 FY | 47.75 Million EUR | 78.95% |
| 2006 FY | 26.68 Million EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 31430.046% |
| Ansell Limited | 76.5 Million USD | -279.603% |
| Ansell Limited | 76.5 Million USD | -279.603% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | -1096.02% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 17913.05% |
| Psykey, Inc. | -1.32 Million USD | 22034.044% |
| ConvaTec Group Plc | 130.3 Million USD | -122.867% |
| ConvaTec Group Plc | 130.3 Million USD | -122.867% |
| Encision Inc. | -691.78 Thousand USD | 42077.903% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 204876.78% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 124007.051% |
| Innovative MedTech Inc. | -7.93 Million USD | 3757.888% |
| LifePoint, Inc. | -15.23 Million USD | 2006.537% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 4363.632% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 61364.979% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 105911.708% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 63363.243% |
| SmileDirectClub, Inc. | -86.4 Million USD | 436.091% |
| Sector 10, Inc. | 7036.00 USD | -4127188.232% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 85.494% |
| SheerVision, Inc. | -71.37 Thousand USD | 406953.844% |
| United Health Products, Inc. | -2.62 Million USD | 11170.013% |
| Vasamed, Inc. | -4.88 Million USD | 6040.812% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 12258.259% |
| Yubo International Biotech Limited | -1.2 Million USD | 24203.954% |